Dihydroartemisinin-piperaquine (DHA-PQ) is under study for intermittent preventive treatment during pregnancy (IPTp), but it may accelerate selection for drug resistance.
intermittent preventive treatment during pregnancy (IPTp)
Antimicrob. Agents Chemother. January 2019 63:e01393-18
Malaria Journal 2014, 13 :162 (30 April 2014)
In the study area, late first ANC clinic enrolment and fewer clinic visits may prevent the uptake of two SP doses and education on early and regular ANC clinic visits can increase IPTp coverage.